Correlation Between Magenta Therapeutics and GeoVax Labs
Can any of the company-specific risk be diversified away by investing in both Magenta Therapeutics and GeoVax Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Magenta Therapeutics and GeoVax Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Magenta Therapeutics and GeoVax Labs, you can compare the effects of market volatilities on Magenta Therapeutics and GeoVax Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Magenta Therapeutics with a short position of GeoVax Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Magenta Therapeutics and GeoVax Labs.
Diversification Opportunities for Magenta Therapeutics and GeoVax Labs
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Magenta and GeoVax is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Magenta Therapeutics and GeoVax Labs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeoVax Labs and Magenta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Magenta Therapeutics are associated (or correlated) with GeoVax Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeoVax Labs has no effect on the direction of Magenta Therapeutics i.e., Magenta Therapeutics and GeoVax Labs go up and down completely randomly.
Pair Corralation between Magenta Therapeutics and GeoVax Labs
If you would invest 82.00 in Magenta Therapeutics on September 23, 2024 and sell it today you would earn a total of 0.00 from holding Magenta Therapeutics or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 4.76% |
Values | Daily Returns |
Magenta Therapeutics vs. GeoVax Labs
Performance |
Timeline |
Magenta Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
GeoVax Labs |
Magenta Therapeutics and GeoVax Labs Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Magenta Therapeutics and GeoVax Labs
The main advantage of trading using opposite Magenta Therapeutics and GeoVax Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Magenta Therapeutics position performs unexpectedly, GeoVax Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeoVax Labs will offset losses from the drop in GeoVax Labs' long position.Magenta Therapeutics vs. Assembly Biosciences | Magenta Therapeutics vs. Instil Bio | Magenta Therapeutics vs. Nuvation Bio | Magenta Therapeutics vs. Achilles Therapeutics PLC |
GeoVax Labs vs. Fate Therapeutics | GeoVax Labs vs. Sana Biotechnology | GeoVax Labs vs. Caribou Biosciences | GeoVax Labs vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
CEOs Directory Screen CEOs from public companies around the world | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |